MYG1-AS1

Across TCGA pan-cancer cohorts, MYG1-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MYG1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MYG1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MYG1-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

KIRC, ACC, and UVM are the cancer types where MYG1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.487	0.735	<.001	185	view →
ACC	DFS	Median	All	0.486	0.826	<.001	163	view →
UVM	OS	Median	All	0.440	0.812	<.001	135	view →
COAD	OS	Tertile	All	0.495	0.681	.001	86	view →
LIHC	DFS	Tertile	All	0.430	0.618	<.001	76	view →
MESO	OS	Tertile	All	0.383	0.717	<.001	56	view →
LGG	DFS	Tertile	All	0.636	0.808	<.001	38	view →
KIRP	OS	Tertile	All	0.545	0.905	.001	34	view →
UCS	OS	Median	IV	0.404	0.752	.013	30	view →
UCEC	DFS	Tertile	All	0.500	0.677	<.001	30	view →
PRAD	DFS	Median	All	0.647	0.900	<.001	24	view →
LAML	DFS	Median	All	0.482	0.642	.012	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MYG1-AS1–KIRC (DFS)

Open the KIRC breakdown →